Hung-Ta Wo
Overview
Explore the profile of Hung-Ta Wo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
367
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang P, Liu Z, Huang Y, Chen J, Chou C, Wo H, et al.
Comput Biol Med
. 2025 Feb;
188:109871.
PMID: 39986199
Background: The stroke risk in patients with subclinical atrial fibrillation (AF) is underestimated. By identifying patients at high risk of embolic stroke, health-care professionals can make more informed decisions regarding...
2.
Lee H, Chang P, Wo H, Chou S, Chou C
Int J Mol Sci
. 2025 Jan;
26(2).
PMID: 39859328
The electrophysiological mechanisms underlying melatonin's actions and the electrophysiological consequences of superimposed therapeutic hypothermia (TH) in preventing cardiac ischemia-reperfusion (IR) injury-induced arrhythmias remain largely unknown. This study aimed to unveil...
3.
Lee H, Chang P, Wo H, Liu H, Wen M, Chou C
Pharmacology
. 2024 Oct;
:1-14.
PMID: 39467530
Introduction: Eleclazine is a highly selective late sodium current inhibitor, possibly effective in reducing ventricular fibrillation (VF) in heart failure (HF) with ischemia-reperfusion (IR) injury. The electrophysiological effects of eleclazine...
4.
Chang P, Lee H, Wo H, Liu H, Wen M, Chou C
PLoS One
. 2024 Apr;
19(4):e0301970.
PMID: 38626004
Background: The VICTORIA trial demonstrated a significant decrease in cardiovascular events through vericiguat therapy. This study aimed to assess the potential mechanisms responsible for the reduction of cardiovascular events with...
5.
Chou C, Liu Z, Chang P, Liu H, Wo H, Lee W, et al.
Can J Cardiol
. 2024 Jan;
40(4):585-594.
PMID: 38163477
Background: The role of P-wave in identifying left atrial enlargement (LAE) with the use of artificial intelligence (AI)-enabled electrocardiography (ECG) models is unclear. It is also unknown if AI-enabled single-lead...
6.
Chang P, Liu Z, Huang Y, Hsu Y, Chen J, Lin C, et al.
Front Cardiovasc Med
. 2023 Nov;
10:1245614.
PMID: 37965090
Background: The risk of mortality is relatively high among patients who visit the emergency department (ED), and stratifying patients at high risk can help improve medical care. This study aimed...
7.
Liu H, Wo H, Chang P, Lee H, Wen M, Chou C
Heliyon
. 2023 Jun;
9(6):e16835.
PMID: 37332966
Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) reduce new-onset atrial fibrillation (AF) in patients with type 2 diabetes mellitus (T2DM). We aimed to determine the long-term effects of SGLT2i on atrial...
8.
Huang Y, Hsu Y, Liu Z, Lin C, Tsai R, Chen J, et al.
Front Cardiovasc Med
. 2023 Mar;
10:1070641.
PMID: 36960474
Background: Left ventricular systolic dysfunction (LVSD) characterized by a reduced left ventricular ejection fraction (LVEF) is associated with adverse patient outcomes. We aimed to build a deep neural network (DNN)-based...
9.
Chou C, Lee H, Wo H, Chang P, Chiang C, Chiu K, et al.
Int J Cardiol
. 2022 Oct;
371:160-166.
PMID: 36220506
Background: High premature ventricular complex (PVC) burden may increase the risk of left ventricular dysfunction and all-cause mortality. We aimed to evaluate maternal and neonatal outcomes of pregnant women with...
10.
Wei T, Chandy M, Nishiga M, Zhang A, Kumar K, Thomas D, et al.
Cell
. 2022 Jun;
185(13):2387-2389.
PMID: 35750035
No abstract available.